Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as oxaliplatin, irinotecan, and capecitabine, work in
different ways to stop tumor cells from dividing so they stop growing or die. Giving more
than one chemotherapy drug may kill more tumor cells. This phase II trial is studying how
well giving oxaliplatin together with irinotecan and capecitabine works in treating patients
with metastatic or inoperable locally advanced gastric cancer or gastroesophageal junction
adenocarcinoma (cancer).